<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Pain]]></title>
    <link>https://www.leadingmarketresearch.com/pharmaceuticals-biotechnology/pharmaceuticals/diseases-conditions/pain-1</link>
    <description><![CDATA[Pain]]></description>
    <pubDate>Thu, 18 Jun 2026 06:34:07 +0000</pubDate>
    <generator>Zend_Feed</generator>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Back Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players]]></title>
      <link>https://www.leadingmarketresearch.com/back-pain-drugs-in-development-by-stages-target-moa-roa-molecule-type-a</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Back Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Back Pain pipeline landscape.<br><br>The report provides comprehensive information on the therapeutics under development for Back Pain, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.<br><br>The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.<br><br>The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinic...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-226666"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 12 Jul 2022 13:59:20 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Low Back Pain - Pipeline Review, H1 2020]]></title>
      <link>https://www.leadingmarketresearch.com/low-back-pain-pipeline-review-h1-2020</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Low Back Pain - Pipeline Review, H1 2020, provides an overview of the Low Back Pain (Central Nervous System) pipeline landscape.<br><br>Low back pain can happen anywhere below the ribs and above the legs. Causes of low back pain include overuse, strain, or injury, aging, arthritis, illness and cancer involving the spine. Symptoms include tingling or burning sensation, a dull achy feeling, or sharp pain and weakness in legs or feet. Treatment includes pain medications such NSAIDs (non-steroidal anti-inflammatory drugs) or opioids and muscle relaxants. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Low Back Pain - Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Low Back Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers th...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-214814"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 07 May 2020 13:13:49 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Osteoarthritis Pain - Pipeline Review, H1 2020]]></title>
      <link>https://www.leadingmarketresearch.com/osteoarthritis-pain-pipeline-review-h1-2020</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis Pain - Pipeline Review, H1 2020, provides an overview of the Osteoarthritis Pain (Central Nervous System) pipeline landscape.<br><br>Osteoarthritis pain is the most common symptom associated with osteoarthritis which causes disruption of the cartilage. If the condition worsens, it leads to rubbing of the bones against each other causing even more pain and loss of movement. Risk factors are age, joint injury, obesity and heredity. Treatment includes weight control, exercise and medications. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Osteoarthritis Pain - Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Osteoarthritis Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological actio...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-214815"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 07 May 2020 13:13:49 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Musculoskeletal Pain Global Clinical Trials Review, H2, 2019]]></title>
      <link>https://www.leadingmarketresearch.com/musculoskeletal-pain-global-clinical-trials-review-h2-2019</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Musculoskeletal Pain Global Clinical Trials Review, H2, 2019&quot; provides an overview of Treatment Musculoskeletal Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Musculoskeletal Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. <br><br>The report enhances the decision making capabilities and helps to create an effective counter stra...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-213656"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 24 Feb 2020 15:56:48 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Global Neuropathic Pain Management Market Research Report 2019-2023]]></title>
      <link>https://www.leadingmarketresearch.com/global-neuropathic-pain-management-market-research-report-2019-2023</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Neuropathic Pain Management Report by Material, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). 

In this report, the global Neuropathic Pain Management market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2023, growing at a CAGR of XX% during the period 2019 to 2023.

The report firstly introduced the Neuropathic Pain Management basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-208924"><span class="price">$2,850.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 25 Jul 2019 11:27:44 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Complex Regional Pain Syndrome (Sympathetic Reflex Dystrophy/Reflex Sympathetic Dystrophy) - Pipeline Review, H1 2019]]></title>
      <link>https://www.leadingmarketresearch.com/complex-regional-pain-syndrome-sympathetic-reflex-dystrophy-reflex-sympath</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Complex Regional Pain Syndrome - Pipeline Review, H1 2019, provides an overview of the Complex Regional Pain Syndrome (Central Nervous System) pipeline landscape.<br><br>Complex regional pain syndrome (CRPS) is a chronic pain condition that most often affects one limb usually after an injury. CRPS is divided into two types: CRPS-I (Individuals without a confirmed nerve injury) and CRPS-II (when there is an associated, confirmed nerve injury). Symptoms include stiffness in affected joints, changes in nail and hair growth patterns, dystonia and abnormal sweating pattern. Treatment includes bisphosphonates, non-steroidal anti-inflammatory drugs, opioids and local anesthetic creams. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Complex Regional Pain Syndrome - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Complex Regional Pain Syndrome (Central Nervous ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-208062"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 26 Mar 2019 12:29:57 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Abdominal Pain Global Clinical Trials Review, H2, 2018]]></title>
      <link>https://www.leadingmarketresearch.com/abdominal-pain-global-clinical-trials-review-h2-2018</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Abdominal Pain Global Clinical Trials Review, H2, 2018&quot; provides an overview of Abdominal Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Abdominal Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive ad...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-206968"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 07 Dec 2018 15:32:55 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Visceral Pain Global Clinical Trials Review, H2, 2018]]></title>
      <link>https://www.leadingmarketresearch.com/visceral-pain-global-clinical-trials-review-h2-2018</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Visceral Pain Global Clinical Trials Review, H2, 2018&quot; provides an overview of Visceral Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Visceral Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advan...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-206603"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 06 Dec 2018 11:06:52 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Pain Drug Development Pipeline Review, 2018]]></title>
      <link>https://www.leadingmarketresearch.com/pain-drug-development-pipeline-review-2018</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>This report provides an overview of the pipeline landscape for pain disorders. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for post-operative pain, fibromyalgia, complex regional pain syndrome (CRPS) and visceral pain, and features dormant and discontinued products.<br><br>Pain is one of the main post-operative adverse outcomes causing distress to patients. Causes of post-operative pain include peripheral nerve damage during surgery, inflammation at the site of the wound and damage to bodily tissues during surgery. Risk factors include site of the operation, age, level of fear or anxiety, surgical procedure, personal preference and response to agents given. Treatment for post-operative pain includes analgesia and anesthetics. There are 74 products in development for this indication.<br><br>Fibromyalgia is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues. Symptoms include fatigue, depression, headaches, and pain o...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-205298"><span class="price">$3,995.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 30 Nov 2018 11:36:19 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Low Back Pain - Pipeline Review, H2 2018]]></title>
      <link>https://www.leadingmarketresearch.com/low-back-pain-pipeline-review-h2-2018</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Low Back Pain - Pipeline Review, H2 2018, provides an overview of the Low Back Pain (Central Nervous System) pipeline landscape.<br><br>Low back pain can happen anywhere below the ribs and above the legs. Causes of low back pain include overuse, strain, or injury, aging, arthritis, illness and cancer involving the spine. Symptoms include tingling or burning sensation, a dull achy feeling, or sharp pain and weakness in legs or feet. Treatment includes pain medications such NSAIDs (non-steroidal anti-inflammatory drugs) or opioids and muscle relaxants. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Low Back Pain - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Low Back Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers th...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-204856"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 29 Nov 2018 13:32:16 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Tendon and Ligament Pain Global Clinical Trials Review, H2, 2018]]></title>
      <link>https://www.leadingmarketresearch.com/tendon-and-ligament-pain-global-clinical-trials-review-h2-2018</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Tendon and Ligament Pain Global Clinical Trials Review, H2, 2018&quot; provides an overview of Tendon and Ligament Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Tendon and Ligament Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter str...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-204216"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 17 Oct 2018 16:06:20 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Traumatic Pain Global Clinical Trials Review, H2, 2018]]></title>
      <link>https://www.leadingmarketresearch.com/traumatic-pain-global-clinical-trials-review-h2-2018</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Traumatic Pain Global Clinical Trials Review, H2, 2018&quot; provides an overview of Traumatic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Traumatic Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive ad...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-204247"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 17 Oct 2018 16:06:20 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Low Back Pain Global Clinical Trials Review, H2, 2017]]></title>
      <link>https://www.leadingmarketresearch.com/low-back-pain-global-clinical-trials-review-h2-2017</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Low Back Pain Global Clinical Trials Review, H2, 2017&quot; provides an overview of Low Back Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Low Back Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advan...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-200366"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 18 Jan 2018 13:06:38 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Acute Pain Global Clinical Trials Review, H1, 2017]]></title>
      <link>https://www.leadingmarketresearch.com/acute-pain-global-clinical-trials-review-h1-2017</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Acute Pain Global Clinical Trials Review, H1, 2017&quot; provides an overview of Acute Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.<br>...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-193232"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 07 Apr 2017 11:35:17 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Pain Management - Medical Devices Pipeline Assessment, 2016]]></title>
      <link>https://www.leadingmarketresearch.com/pain-management-medical-devices-pipeline-assessment-2016</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s Medical Devices sector report, “Pain Management - Medical Devices Pipeline Assessment, 2016&quot; provides an overview of Pain Management currently in pipeline stage.<br><br>The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Pain Management pipeline products.<br><br>This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData&#039;s team of industry experts.<br><br>*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.<br><br><b>Scope</b><br><br>- Extensive coverage of the Pain Management under development<br>- The report reviews details of major pipeline pro...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-188497"><span class="price">$4,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 16 Jan 2017 11:48:58 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Inflammatory Pain Global Clinical Trials Review, H2, 2016]]></title>
      <link>https://www.leadingmarketresearch.com/inflammatory-pain-global-clinical-trials-review-h2-2016</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Inflammatory Pain Global Clinical Trials Review, H2, 2016&quot; provides an overview of Inflammatory Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Inflammatory Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to gain compe...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-187397"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 11 Jan 2017 12:42:31 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Joint Pain Global Clinical Trials Review, H2, 2016]]></title>
      <link>https://www.leadingmarketresearch.com/joint-pain-global-clinical-trials-review-h2-2016</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Joint Pain Global Clinical Trials Review, H2, 2016&quot; provides an overview of Joint Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Joint Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.<br>...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-187401"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 11 Jan 2017 12:42:31 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cancer Pain Global Clinical Trials Review, H2, 2016]]></title>
      <link>https://www.leadingmarketresearch.com/cancer-pain-global-clinical-trials-review-h2-2016</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Cancer Pain Global Clinical Trials Review, H2, 2016&quot; provides an overview of Cancer Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Cancer Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.<...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-187402"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 11 Jan 2017 12:42:31 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Dental Pain - Pipeline Review, H2 2016]]></title>
      <link>https://www.leadingmarketresearch.com/dental-pain-pipeline-review-h2-2016</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Dental Pain - Pipeline Review, H2 2016, provides an overview of the Dental Pain (Central Nervous System) pipeline landscape.<br><br>A pain in the tooth is called dental pain. This can be caused by tooth decay, damaged filling, tooth fracture, etc. Symptoms of a toothache may include: tooth pain that may be sharp, throbbing, or constant. In some people, pain results only when pressure is applied to the tooth. Swelling around the tooth, fever or headache and foul-tasting drainage from the infected tooth occurs. Treatment for a toothache depends on the cause. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Dental Pain - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Dental Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-186424"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 09 Dec 2016 10:18:51 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Epiomic Epidemiology Series: Lower Back Pain and Sciatica Forecast in 9 Major Markets 2016-2026]]></title>
      <link>https://www.leadingmarketresearch.com/epiomic-epidemiology-series-lower-back-pain-and-sciatica-forecast-in-9-maj</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Lower Back Pain and Sciatica in 9 Major Markets
Low back pain (LBP) is defined as experiencing musculoskeletal pain, muscle tension, or stiffness localized below the bottom edge of the rib cage and above the gluteal sulcus, with or without sciatica, and is defined as chronic when it persists for 12 weeks or more. This pain may be caused by a variety of diseases and disorders that affect the lumbar spine region.
This report provides the current prevalent population for Lower Back Pain across 9 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan and Mexico) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity. 
Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Lower Back Pain have been quantified and presented alongside the overall prevalence fig...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-185718"><span class="price">$6,400.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 18 Oct 2016 09:19:13 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Acute Pain - Pipeline Review, H2 2016]]></title>
      <link>https://www.leadingmarketresearch.com/acute-pain-pipeline-review-h2-2016</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct’s, ‘Acute Pain - Pipeline Review, H2 2016’, provides an overview of the Acute Pain pipeline landscape. <br><br>The report provides comprehensive information on the therapeutics under development for Acute Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Acute Pain and features dormant and discontinued projects. <br><br>Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featu...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-184479"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 15 Sep 2016 21:22:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Post-Operative Pain - Pipeline Review, H2 2016]]></title>
      <link>https://www.leadingmarketresearch.com/post-operative-pain-pipeline-review-h2-2016</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct’s, ‘Post-Operative Pain - Pipeline Review, H2 2016’, provides an overview of the Post-Operative Pain pipeline landscape. <br><br>The report provides comprehensive information on the therapeutics under development for Post-Operative Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects. <br><br>Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filin...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-184654"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 15 Sep 2016 21:22:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Ocular Pain Global Clinical Trials Review, H2, 2016]]></title>
      <link>https://www.leadingmarketresearch.com/ocular-pain-global-clinical-trials-review-h2-2016</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Ocular Pain Global Clinical Trials Review, H2, 2016&quot; provides an overview of Ocular Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Ocular Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.<...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-184385"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 15 Sep 2016 20:23:57 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Sciatic Pain Global Clinical Trials Review, H2, 2016]]></title>
      <link>https://www.leadingmarketresearch.com/sciatic-pain-global-clinical-trials-review-h2-2016</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Sciatic Pain Global Clinical Trials Review, H2, 2016&quot; provides an overview of Sciatic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Sciatic Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantag...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-184398"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 15 Sep 2016 20:23:57 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Post-Operative Pain Global Clinical Trials Review, H1, 2016]]></title>
      <link>https://www.leadingmarketresearch.com/post-operative-pain-global-clinical-trials-review-h1-2016</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Post-Operative Pain Global Clinical Trials Review, H1, 2016&quot; provides an overview of Post-Operative Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Post-Operative Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to gain...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-178281"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Sun, 19 Jun 2016 18:32:13 +0000</pubDate>
    </item>
  </channel>
</rss>
